Barclays
June 3, 2026
Americas Small Cap Research Summary
Market ReportEquitiesConsumer StaplesHealth Care
A summary of recent Barclays research on Americas small-cap stocks, specifically covering updates for Yesway Inc., Arvinas, and Tyra Biosciences.
Key Takeaways
- 1.Yesway Inc. (YSWY) reported strong Q1 results and maintains room for upside in its guidance through the year.
- 2.Arvinas (ARVN) is de-prioritizing its ARV-806 program, a move consistent with its strategy to focus on differentiated programs.
- 3.Tyra Biosciences (TYRA) has significant catalysts in 2024, including NMIBC data in August and achondroplasia data in Q4.
Table of Contents
- Summary of Changes
- Publications Summary
- Consumer
- Healthcare
- Explanation of Summary of Changes table
- Analyst(s) Certification(s)
- Important Disclosures
- Availability of Disclosures
- Risk Disclosure(s)
- Guide to the Barclays Fundamental Equity Research Rating System
- Industry View
- Distribution of Ratings
- Guide to the Barclays Research Price Target
- Types of investment recommendations produced by Barclays Equity Research
- Disclosure of other investment recommendations produced by Barclays Equity Research
- Legal entities involved in producing Barclays Research
- Disclaimer
Access the Full Report
Get unlimited access to institutional research reports with a 14-day free trial.
Authors
Seth SigmanEtzer DaroutLukas ShumwayEliana Merle
Securities
YSWYARVNTYRA
Themes
Small Cap Equity ResilienceBiotech Clinical Catalysts
Regions
North AmericaUnited States